AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
RSS SUMMARY · AGGREGATED FROM CNBC
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Marvell Technology and Flex to join S&P 500 index, replacing Pool and Campbell’s
CNBC·4h ago·3 min read
US
Meta’s stock sinks on report company could raise tens of billions of dollars to fund AI push
CNBC·6h ago·3 min read
US
Google to pay SpaceX $920 million a month for compute capacity at xAI data centers
CNBC·5h ago·3 min read
US
Trump wants Bill Pulte to fire big chunk of national intelligence office staff: WSJ
CNBC·7h ago·3 min read
Related
On this beat
Health
Level 2 – Chikungunya in French Guiana
CDC·1d ago·3 min read
Health
Level 1 – Hepatitis A in Canada
CDC·1d ago·3 min read
Health
A scientist says his group has edited genes in an embryo, a landmark scientific move. The practice is controversial, because it raises the prospect of eugenics.
TWSJ·4h ago·3 min read
Health
Level 1 – Hepatitis A in Canada
CDC·1d ago·3 min read